THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Quarterly Common Stock, Shares Authorized from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Therapeutic Solutions International, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q3 2024.
  • Therapeutic Solutions International, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 6.5B shares, a 18.2% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 6.5B +1B +18.2% Sep 30, 2024 10-Q 2024-11-20
Q2 2024 6.5B +2B +44.3% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 6.5B +2B +44.4% Mar 31, 2024 10-Q 2024-05-30
Q4 2023 5.5B +2B +57.1% Dec 31, 2023 10-Q 2024-11-20
Q3 2023 5.5B +2B +57.1% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 4.51B +1.01B +28.7% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 4.5B +1B +28.6% Mar 31, 2023 10-Q 2023-05-16
Q4 2022 3.5B 0 0% Dec 31, 2022 10-K 2024-04-17
Q3 2022 3.5B 0 0% Sep 30, 2022 10-Q 2022-11-17
Q2 2022 3.5B 0 0% Jun 30, 2022 10-Q 2022-08-19
Q1 2022 3.5B 0 0% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 3.5B 0 0% Dec 31, 2021 10-K 2023-03-29
Q3 2021 3.5B +1B +40% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 3.5B +1B +40% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 3.5B 0 0% Mar 31, 2021 10-Q/A 2021-05-21
Q4 2020 3.5B +1B +40% Dec 31, 2020 10-K 2022-03-31
Q3 2020 2.5B 0 0% Sep 30, 2020 10-Q 2020-11-17
Q2 2020 2.5B 0 0% Jun 30, 2020 10-Q/A 2020-08-24
Q1 2020 3.5B +1B +40% Mar 31, 2020 10-Q/A 2020-07-09
Q4 2019 2.5B 0 0% Dec 31, 2019 10-Q 2020-11-17
Q3 2019 2.5B +1.51B +153% Sep 30, 2019 10-Q 2019-11-20
Q2 2019 2.5B +1.51B +153% Jun 30, 2019 10-Q 2019-08-16
Q1 2019 2.5B +1.51B +153% Mar 31, 2019 10-Q 2019-05-20
Q4 2018 2.5B +1.51B +153% Dec 31, 2018 10-Q 2019-11-20
Q3 2018 990M 0 0% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 990M 0 0% Jun 30, 2018 10-Q 2018-08-17
Q1 2018 990M 0 0% Mar 31, 2018 10-Q/A 2018-05-22
Q4 2017 990M 0 0% Dec 31, 2017 10-K 2019-04-15
Q3 2017 990M +290M +41.4% Sep 30, 2017 10-Q 2017-11-16
Q2 2017 990M +290M +41.4% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 990M +290M +41.4% Mar 31, 2017 10-Q 2017-07-05
Q4 2016 990M 0 0% Dec 31, 2016 10-K 2018-04-17
Q3 2016 700M 0 0% Sep 30, 2016 10-Q 2017-04-17
Q2 2016 700M 0 0% Jun 30, 2016 10-Q 2017-04-13
Q1 2016 700M 0 0% Mar 31, 2016 10-Q 2017-03-09
Q4 2015 990M +290M +41.4% Dec 31, 2015 10-K 2017-06-07
Q3 2015 700M -5M -0.71% Sep 30, 2015 10-Q 2016-08-23
Q2 2015 700M -5M -0.71% Jun 30, 2015 10-Q 2016-07-26
Q1 2015 700M 0 0% Mar 31, 2015 10-Q 2016-07-06
Q4 2014 700M 0 0% Dec 31, 2014 10-K 2016-10-31
Q3 2014 705M +5M +0.71% Sep 30, 2014 10-Q 2016-05-13
Q2 2014 705M +5M +0.71% Jun 30, 2014 10-Q 2016-05-09
Q1 2014 700M 0 0% Mar 31, 2014 10-Q 2016-04-28
Q4 2013 700M 0 0% Dec 31, 2013 10-K 2016-06-16
Q3 2013 700M -1 0% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 700M -1 0% Jun 30, 2013 10-Q 2013-08-12
Q1 2013 700M -1 0% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 700M -1 0% Dec 31, 2012 10-K 2016-04-22
Q3 2012 700M 0 0% Sep 30, 2012 10-Q 2012-11-29
Q2 2012 700M 0 0% Jun 30, 2012 10-Q 2012-11-21
Q1 2012 700M Mar 31, 2012 10-Q 2012-11-19
Q4 2011 700M 0 0% Dec 31, 2011 10-K 2013-03-29
Q3 2011 700M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 700M Jun 30, 2011 10-Q/A 2011-09-01
Q4 2010 700M Dec 31, 2010 10-K 2012-10-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.